MESENCHYMAL STROMAL CELLS MAY ENHANCE RESIDUAL HEALTHY HAEMATOPOIESIS IN LOW-RISK MDS PATIENTS

被引：0

作者：

Jimenez Solas, T. ^{[1
]}

Muntion Olave, S. ^{[1
]}

Lopez, F. ^{[1
]}

Ortega Herrera, R. ^{[1
]}

Martin Izquierdo, M. ^{[2
]}

Gonzalez Martinez, T. ^{[2
]}

Janusz, K. ^{[3
]}

Ezponda, T. ^{[4
]}

Vilas, A. ^{[4
]}

Alfonso, A. ^{[5
]}

Prosper, F. ^{[5
]}

Molero, A. ^{[6
]}

Valcarcel, D. ^{[7
]}

Sanchez-Guijo, F. ^{[1
]}

Diez-Campelo, M. ^{[1
]}

机构：

[1] Hosp Univ Salamanca, IBSAL, Hematol, Salamanca, Spain

[2] Canc Res Ctr Salamanca, Hematol, Salamanca, Spain

[3] Inst Maimonides Invest Biomed Cordoba, Biol Celular Hematol, Cordoba, Spain

[4] Univ Navarra, IDISNA, Ctr Invest Med Aplicada CIMA, Oncol Hematol, Pamplona, Spain

[5] Univ Navarra, IDISNA, Ctr Invest Med Aplicada CIMA, Hematol, Pamplona, Spain

[6] Univ Autonoma Barcelona UAB, Vall dHebron Hosp, Barcelona, Spain

[7] Vall dHebron Inst Oncol VHIO, Expt Hematol Unit, Barcelona, Spain

来源：

LEUKEMIA RESEARCH | 2021年 / 108卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P36

引用

页码：S39 / S39

页数：1

共 50 条

[21] Preoperative Testing Is Overused in Healthy Patients Undergoing Low-Risk Operations
Antunez, Alexis
Richburg, Caroline E.
Pesavento, Cecilia M.
Vastardis, Andrew
Gavrila, Valerie
Cuttitta, Anthony
Nathan, Hari
Dossett, Lesly A.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S275 - S275
[22] ANALYSIS OF EXPANSION MESENCHYMAL STROMAL IN PATIENTS WITH LOW RISK MYELODYSPLASTIC SYNDROME
Duarte, F.
Lemes, R.
Vasconcelos, J.
Rocha, F.
Zalcberg, I.
Coutinho, D.
Silla, L.
Valim, V.
Barbosa, M.
Santos, T.
Goncalves, R.
Carlos, L.
Vasconcelos, P.
LEUKEMIA RESEARCH, 2015, 39 : S91 - S92
[23] CZT camera systems may provide better risk stratification for low-risk patients
Robert J. H. Miller
Donghee Han
Alan Rozanski
Heidi Gransar
John D. Friedman
Sean Hayes
Louise Thomson
Balaji Tamarappoo
Piotr J. Slomka
Daniel S. Berman
Journal of Nuclear Cardiology, 2021, 28 : 2927 - 2936
[24] CZT camera systems may provide better risk stratification for low-risk patients
Miller, Robert J. H.
Han, Donghee
Rozanski, Alan
Gransar, Heidi
Friedman, John D.
Hayes, Sean
Thomson, Louise
Tamarappoo, Balaji
Slomka, Piotr J.
Berman, Daniel S.
JOURNAL OF NUCLEAR CARDIOLOGY, 2021, 28 (06) : 2927 - 2936
[25] Identifying a Low-risk Group for Residual Disease in Patients with Ductal Carcinoma In Situ
Murphy, B. L.
Gonzalez, A.
Conners, A. L.
Henrichsen, T. L.
Keeney, M. G.
Chen, B.
Nguyen, T. T.
Shah, H. N.
Harmsen, W.
Habermann, E. B.
Jakub, J. W.
ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S58 - S58
[26] Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients
M Y Follo
S Mongiorgi
C Clissa
S Paolini
G Martinelli
A M Martelli
G Fioravanti
L Manzoli
C Finelli
L Cocco
Leukemia, 2012, 26 : 2474 - 2482
[27] Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients
Follo, M. Y.
Mongiorgi, S.
Clissa, C.
Paolini, S.
Martinelli, G.
Martelli, A. M.
Fioravanti, G.
Manzoli, L.
Finelli, C.
Cocco, L.
LEUKEMIA, 2012, 26 (12) : 2474 - 2482
[28] Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment
Follo, Matilde Y.
Mongiorgi, Sara
Clissa, Cristina
Fili, Carla
Colombi, Chiara
Baccarani, Michele
Martinelli, Giovanni
Russo, Domenico
Manzoli, Lucia
Martelli, Alberto M.
Finelli, Carlo
Cocco, Lucio
BLOOD, 2010, 116 (21) : 108 - 108
[29] Mesenchymal stromal cells enhance the engraftment of low numbers of hematopoietic stem cells in a mouse model of autologous transplantation
Fernandez-Garcia, M.
Yanez, R.
Sanchez-Dominguez, R.
Bueren, J. A.
Lamana, M. L.
HUMAN GENE THERAPY, 2014, 25 (11) : A55 - A55
[30] New risk group staging according to new R-IPSS of 25 patients with low-risk MDS
Tatic, A.
Jardan, C.
Georgescu, O.
Stanca, O.
Vasilica, M.
Badelita, S.
Crisan, A. M.
Colita, A.
Colita, D.
Vulcan, G.
Lupu, A. R.
Coriu, D.
LEUKEMIA RESEARCH, 2013, 37 : S98 - S99

← 1 2 3 4 5 →